User talk:CommWillRiker78

References

Remember that when adding content about health, please only use high-quality reliable sources as references. We typically use review articles, major textbooks and position statements of national or international organizations. WP:MEDHOW walks you through editing step by step. A list of resources to help edit health content can be found here. The edit box has a built-in citation tool to easily format references based on the PMID or ISBN. We also provide style advice about the structure and content of medicine-related encyclopedia articles. The welcome page is another good place to learn about editing the encyclopedia. If you have any questions, please feel free to drop me a note. Boghog (talk) 04:01, 1 September 2016 (UTC)[reply]

Mammary Analogue Secretory Carcinoma (MASC) Tumors

Mammary analogue secretory carcinoma (MASC) of the salivary gland was first described by Skálová in 2010 [1]. A chromosome translocation was found to be identical to the t(12;15) (p13;q25)found in secretory carcinoma of the breast. This fusion is between the ETV6 and NTRK3 genes https://en.wikipedia.org/wiki/ETV6-NTRK3_gene_fusion.

The fusion gene product contains the N-terminus of the transcription faction TEL that is responsible for dimerization/ polymerization https://en.wikipedia.org/wiki/ETV6. The C-terminus of the protein product of the gene fusion contains the C-terminus of the receptor tyrosine kinase TrkC https://en.wikipedia.org/wiki/Tropomyosin_receptor_kinase_C. It should be noted that the fusion protein lacks regulation by growth factors. Since it's discovery, much of the literature concerning MASC has addressed the challenge of differentiating it from similar appear cancers such as acinic cell carcinoma (https://en.wikipedia.org/wiki/Acinic_cell_carcinoma AciCC), low grade cribriform cystadenocarcinoma ( https://en.wikipedia.org/wiki/Low-grade_cribriform_cystadenocarcinoma, LGCCC), and adenocarcinoma not otherwise specified (AcNOS). Means of identifying and differentiating MASC rely on histology, protein markers, and genetic markers.

Skálová et al 2010 and 2015 [1,2]

Protein Expression Presence of • S100, a family of calcium binding proteins. Many of the antibodies used in MASC studies are specific to the S100B isoform. https://en.wikipedia.org/wiki/S100B • mammaglobin, https://en.wikipedia.org/wiki/Mammaglobin, a breast cancer marker • cytokeratin CK7, https://en.wikipedia.org/wiki/Keratin_7, an intermediate filament found in epithelial cells. • GATA-3, https://en.wikipedia.org/wiki/GATA3, a transcription factor that is a breast cancer biomarker. • SOX-10, https://en.wikipedia.org/wiki/SOX10, a transcription factor important in neural crest origin cells and in development of the peripheral nervous system. • STAT5a https://en.wikipedia.org/wiki/STAT5A, a transcription factor Absence of • p63 https://en.wikipedia.org/wiki/TP63, a transcription factor in the same family as p53 • DOG1 Discovered On Gastrointestinal Stromal Tumors Protein) otherwise known as Anoctamin-1, https://en.wikipedia.org/wiki/ANO1, a voltage sensitive calcium activated chloride channel.

Histology

• lobulated growth pattern • microcystic https://en.wikipedia.org/wiki/Cyst and glandular spaces • eosinophilic secretions, i.e. stains strongly for eosin Y https://en.wikipedia.org/wiki/Eosin_Y • positive for periodic acid-Schiff https://en.wikipedia.org/wiki/Periodic_acid–Schiff_stain, often after diastase digestion https://en.wikipedia.org/wiki/Diastase. • Vesicular oval nuclei with a single small but prominent nucleolus • absence of basophilic https://en.wikipedia.org/wiki/Haematoxylin or zymogen granules https://en.wikipedia.org/wiki/Zymogengranules found in AciCC

Molecular Biology • Chromosome break at the ETV6 loci using FISH, https://en.wikipedia.org/wiki/Fluorescence_in_situ_hybridization • reverse transcript PCR for the junction between the transcript of the ETV6-NTRK3 gene fusion. • Murphy and coworkers [3] developed a different two step for identifying the molecular component of MASC. In this two step process a tissue section is (1a) screened with pan-receptor tyrosine kinase antibody (1b) screened with specific receptor tyrosine kinase antibodies known to drive cancers, e.g. TrkC (2) Based on the results of immunohistochemistry, next generation sequencing is used to identify the fusion partner. This assay as come to be called the Trailblaze Pharos assay [4] and is part of an ongoing clinical trial [5].

In a 2016 report, Skálová and coworkers investigated the discrepancy between positive FISH results and negative reverse transcriptase PCR for the fusion transcript [2]. Using reverse transcriptase PCR https://en.wikipedia.org/wiki/Reverse_transcription_polymerase_chain_reaction and a more rigorous nested primer system they found evidence for splice variants of the ETV6-NTRK3 fusion gene. They also presented evidence of a different splice variants led to more aggressive forms of MASC [2].

1. Skálová A, Vanecek T, Sima R, Laco J, Weinreb I, Perez-Ordonez B, Starek I, Geierova M, Simpson RH, Passador-Santos F, Ryska A, Leivo I, Kinkor Z, Michal M.(2010)Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol.34(5):599-608. PMID: 20410810 DOI: 10.1097/PAS.0b013e3181d9efcc

2. Skálová A, Vanecek T, Simpson RH, Laco J, Majewska H, Baneckova M, Steiner P, Michal M.(2016) Mammary Analogue Secretory Carcinoma of Salivary Glands: Molecular Analysis of 25 ETV6 Gene Rearranged Tumors With Lack of Detection of Classical ETV6-NTRK3 Fusion Transcript by Standard RT-PCR: Report of 4 Cases Harboring ETV6-X Gene Fusion. Am J Surg Pathol. 40(1):3-13. PMID: 26492182 DOI: 10.1097/PAS.0000000000000537

3. Murphy DA, Ely HA, Shoemaker R, Boomer A, Culver BP, Hoskins I, Haimes JD, Walters RD, Fernandez D, Stahl JA, Lee J, Kim KM, Lamoureux J, Christiansen J.(2016)Detecting Gene Rearrangements in Patient Populations Through a 2-Step Diagnostic Test Comprised of Rapid IHC Enrichment Followed by Sensitive Next-Generation Sequencing.Appl Immunohistochem Mol Morphol. [Epub ahead of print PMID: 27028240 DOI: 10.1097/PAI.0000000000000360

Your submission at Articles for creation: NTRK (gene) (August 9)

Your recent article submission to Articles for Creation has been reviewed! Unfortunately, it has not been accepted because it included copyrighted content, which is not permitted on Wikipedia.

This submission appears to be taken from https://ignyta.com/providers/rx-precision-medicine-pipeline/entrectinib/ntrk-fusions/. Wikipedia cannot accept material copied from elsewhere, unless it explicitly and verifiably has been released to the world under a suitably-free and compatible copyright license or into the public domain and is written in an acceptable tone—this includes material that you own the copyright to. You should attribute the content of a draft to outside sources, using citations, but copying and pasting or closely paraphrasing sources is not acceptable. The entire draft should be written using your own words and structure. Note to reviewers: do not leave copyright violations sitting in the page history. Please follow the instructions here.

You are welcome to write an article on the subject, but please do not use copyrighted work.

Draft:NTRK (gene) may be deleted at any time unless the copied text is removed. Copyrighted work cannot be allowed to remain on Wikipedia.
If you need any assistance, you can ask for help at the Articles for creation help desk or on the reviewer's talk page.
You can also use Wikipedia's real-time chat help from experienced editors.

(t) Josve05a (c) 04:46, 9 August 2017 (UTC)[reply]

Hello! CommWillRiker78, I noticed your article was declined at Articles for Creation, and that can be disappointing. If you are wondering why your article submission was declined, please post a question at the Articles for creation help desk. If you have any other questions about your editing experience, we'd love to help you at the Teahouse, a friendly space on Wikipedia where experienced editors lend a hand to help new editors like yourself! See you there! (t) Josve05a (c) 04:46, 9 August 2017 (UTC)[reply]